oral glp-1 drugs in development Drug Trends: Market & Competition Comparing Ozempic, Wegovy and Other
Description
Medicare remains prohibited from negotiating drug prices under current law, though recent legislation creates slow pathways for future negotiations
Vaduganathan M, Filippatos G, Claggett BL, Desai AS, Jhund PS, Henderson A, Brinker M, Kolkhof P, Schloemer P, Lay-Flurrie J, et al
Just like GLP-1, GLP-1 receptor agonists signal the pancreas to produce more insulin and inhibit the production of glucagon, helping to lower blood sugar
Smarter support is
Income-based patient assistance programs Both manufacturers offer Patient Assistance Programs (PAPs) that provide medications at no cost to qualifying individuals
